Dr. Eamon John McLaughlin, MD

Dr. McLaughlin practices at South Florida ENT Associates, Inc. in Miami Lakes, Florida.

Dr. McLaughlin's NPI, 1538420815, was assigned on June 4, 2012. Dr. McLaughlin graduated from Perelman School of Medicine - Philadelphia in 2012. Dr. McLaughlin holds Florida license ME130648.

Dr. McLaughlin's primary practice is South Florida ENT Associates, Inc., at 15280 Nw 79th Ct, Miami Lakes, FL 33016 in Miami-Dade County. The practice phone is (305) 558-3724.

Dr. McLaughlin's primary practice is South Florida ENT Associates, Inc. in Miami Lakes, Florida. Dr. McLaughlin is also affiliated with Memorial Regional Hospital. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. McLaughlin to 2 more hospitals, 1 group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McLaughlin practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. McLaughlin's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. McLaughlin is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. McLaughlin's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. McLaughlin treats.

CMS data shows 1,554 Medicare services from Dr. McLaughlin across 15 procedure codes in 2024, for 366 Medicare patients. Medicare paid $105,927 for them. Every service was in an office.

CMS counts 366 Medicare patients who saw Dr. McLaughlin in 2024. The largest group is 65 to 74, with 154 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McLaughlin's median patient age at 56, with 54% women.

In 2024, Dr. McLaughlin wrote 1,002 Medicare Part D claims for 391 patients. 96% of them were for generic drugs. CMS names the drug for 917 of them, across 18 drugs with 11 or more claims each, at $19,976 in total drug cost. In 2023, CMS named 866 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. McLaughlin for performance year 2024, reported individually. Dr. McLaughlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McLaughlin as offering telehealth.

Dmand AI links 7 papers to Dr. McLaughlin, published from 2015 to 2017. 2017 was the busiest year, with 2. Dr. McLaughlin's most frequent co-authors are Steven Bernard Cannady, MD, Jason G. Newman, MD and Jean B. Belasco, MD.

CMS Open Payments shows 77 general payments to Dr. McLaughlin from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Intersect ENT, Inc. paid the most, $1,422.

Dr. McLaughlin graduated from Perelman School of Medicine - Philadelphia in 2012. Dr. McLaughlin is a member of NHS.

Dr. McLaughlin is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.